Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cengild Medical BhdXKLS:0243 64 3-Year ROIIC % is 3.83 as of Jun. 2025. GuruFocus rates XKLS:0243 with a GF Score™ of 64/100 and a GF Value™ of RM0.29 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 619 Healthcare Providers & Services companies, Cengild Medical Bhd ranks better than 51.05% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Cengild Medical Bhd's 3-Year ROIIC % for the quarter that ended in Jun. 2025 was 3.83%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Cengild Medical Bhd's 3-Year ROIIC % or its related term are showing as below:
XKLS:0243's 3-Year ROIIC % is ranked better than 51.05% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.46
vs XKLS:0243: 3.83
Cengild Medical Bhd (XKLS:0243) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Cengild Medical Bhd 3-Year ROIIC % Related Terms
Cengild Medical Bhd 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Cengild Medical Bhd's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0243 vs HCA, THC, DVA: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Cengild Medical Bhd's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cengild Medical Bhd 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cengild Medical Bhd's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Cengild Medical Bhd's 3-Year ROIIC % falls into.
Cengild Medical Bhd's 3-Year ROIIC % for the quarter that ended in Jun. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 11.16687 (Jun. 2025) - 8.969064 (Jun. 2022) )
/
( 88.147 (Jun. 2025) - 30.791 (Jun. 2022) )
=
2.197806
/
57.356
=
3.83%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Cengild Medical Bhd (XKLS:0243) has a 3-Year ROIIC % of 3.83 as of Jun. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Cengild Medical Bhd and its competitors. According to the industry distribution chart, Cengild Medical Bhd ranks #303 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 48.9%.
Is Cengild Medical Bhd's 3-Year ROIIC % too high?
Cengild Medical Bhd's current 3-Year ROIIC % is 3.83. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.46. Cengild Medical Bhd's value of 3.83 is 10.7% above this industry median. Based on the distribution chart, Cengild Medical Bhd ranks #303 out of 619 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Cengild Medical Bhd has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cengild Medical Bhd ranks #303 out of 619 companies for 3-Year ROIIC %. This puts Cengild Medical Bhd in the upper half of its industry. The industry median 3-Year ROIIC % is 3.46. Cengild Medical Bhd's value of 3.83 is 10.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.46, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cengild Medical Bhd's current 3-Year ROIIC % of 3.83 is 10.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Cengild Medical Bhd and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cengild Medical Bhd's current 3-Year ROIIC % is 3.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.29, compared to a current price of RM0.19 — trading 34.5% below its estimated fair value. The current 3-Year ROIIC % is 3.83 and 10.7% above the Healthcare Providers & Services industry median of 3.46. Cengild Medical Bhd's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current 3-Year ROIIC % is 3.83 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?
Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued.
The current stock price of RM0.19 is trading 34.5% below its estimated GF Value™ of RM0.29.
GuruFocus considers Cengild Medical Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0243:
3-Year ROIIC %: 3.83
GF Value™: RM0.29 vs. price of RM0.19 (34.5% below fair value)
Industry Position: 10.7% above the Healthcare Providers & Services median (#303 of 619)
No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
64GF Score
Get the complete analysis for XKLS:0243
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0243 has been successfully added to your 
